Overview
We're excited to have Robert Longyear, VP of Digital Health and Innovation at Wanderly and Avenue Health, back for a discussion about direct contracting and why this time is different for value-based, at-risk primary care models. Avenue, a Wanderly company, partners with providers to offer fully-staffed remote-patient monitoring and virtual care programs and also works with payors to provide evidence-based care management solutions.
We've seen One Medical (ONEM), which remains a Best Idea Long, moving closer to taking risk this year, most recently with its jump into Medicare via the acquisition of Iora, Cano (CANO) is buying University Health Care for $600MM, and we continue to work on Oak Street (OSH) in the background. M&A activity is likely to remain hot as providers seek scale in the race to win over health care consumers (especially those 65+) and capitalize on all that's broken in the US Health Care system.
Hedgeye Health Care Sector Head Tom Tobin will lead the discussion, which we expect to cover:
- Contracting with Medicare Advantage plans (full-risk) vs. direct contracting
- What patients expect and get with Iora, OSH, and ChenMed, among others, and why the model(s) are sustainable
- How and why the new primary care model is working; the role of technology/analytics and RPM and why physicians like it
- Implications for telehealth/telemedicine providers like Amwell (AMWL) and Teladoc (TDOC)
- Amazon Care - growth and disruption
We look forward to hearing Robert's views on the above, as well as fielding any questions you may have.
|
Executive Insights Call Invite | June 22, 12:30 PM ET | This Time is Different for Value-Based/At-Risk Models Please join us on Tues. June 22 @ 12:30 PM ET for a fireside chat format Q&A with Robert Longyear - Add to Calendar Subscribers: CLICK HERE for event details (includes video and materials link). |
About the Speaker
Robert Longyear is VP of Digital Health and Innovation at Wanderly and Avenue Health, a Wanderly company. He is the author of Innovating for Wellness, a book that explores the intersection of health policy and health technology innovation. His second book on remote-patient monitoring and virtual care will be published by Routledge, Taylor & Francis in the HIMSS series in 2021.
Robert has worked across the healthcare industry for a number of organizations including Medicaid Health Plans of America in policy analysis, Wellcare Health Plans in clinical quality improvement, and the Institute for Medicaid Innovation (IMI). At the Institute for Medicaid Innovation, he led two projects in conjunction with major Medicaid health plans looking at national best practices in high-risk care coordination and social determinants of health data collection at the point of Medicaid enrollment. In his career in health technology, Robert was Director of Product at a pharmacy-focused mHealth technology company where he took the company to a contract with the United States Air Force and lead the submission of three NIH SBIR grant proposals. In biotechnology, Robert worked for Synergene Therapeutics, while in school, studying the pharmacokinetics of nanotechnology-delivered p53 gene therapy in solid tumors. Robert has consulted for several innovative biotechnology and digital health companies from start-ups to market leaders.
His research work has been published by the Institute for Medicaid Innovation, NEJM Catalyst, and the American Psychological Association Practice Innovations. His main focus is on innovations for healthcare delivery and care management as well as the application of digital health technologies to healthcare services, broadly. Specifically, Robert has expertise in remote-patient monitoring, virtual care, and the use of digital experiences to solve problems in healthcare services.
Please send any questions for Robert and Tom to .
We hope you can join us!
Thomas Tobin
Managing Director
Twitter
LinkedIn
